We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+4.08%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
AUM
$866M
AUM Growth
-$48.6M
Cap. Flow
-$80M
Cap. Flow %
-9.24%
Top 10 Hldgs %
32.69%
Holding
54
New
1
Increased
Reduced
36
Closed

Top Buys

Rank Stock Value
1
ADM icon
Archer Daniels Midland
ADM
+$187K

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$3.61M
2
PM icon
Philip Morris
PM
+$3.57M
3
PPL
PPL Corp
PPL
+$3.26M
4
T icon
AT&T
T
+$3.14M
5
EOG icon
EOG Resources
EOG
+$3.03M

Sector Composition

Rank Sector Weight
1 Healthcare 26.3%
2 Energy 10.53%
3 Utilities 9.99%
4 Consumer Staples 9.77%
5 Communication Services 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
26
Oracle
ORCL
$442B
$22.4M 2.59%
547,656
-41,400
-7% -$1.65M
FDX icon
27
FedEx
FDX
$77.3B
$21.9M 2.53%
144,499
-12,500
-8% -$2.03M
MSFT icon
28
Microsoft
MSFT
$3.66T
$21.8M 2.51%
425,575
-39,300
-8% -$2.04M
EOG icon
29
EOG Resources
EOG
$75.1B
$21.6M 2.49%
258,450
-37,850
-13% -$3.03M
GOOGL icon
30
Alphabet (Google) Class A
GOOGL
$4.2T
$21.3M 2.45%
604,400
-53,000
-8% -$1.95M
JNJ icon
31
Johnson & Johnson
JNJ
$629B
$19.2M 2.21%
158,010
-16,100
-9% -$1.83M
TMO icon
32
Thermo Fisher Scientific
TMO
$223B
$18.9M 2.18%
127,785
-11,475
-8% -$1.69M
AMGN icon
33
Amgen
AMGN
$225B
$16.9M 1.95%
110,925
-7,475
-6% -$1.16M
ABT icon
34
Abbott
ABT
$192B
$15.5M 1.79%
393,665
-25,300
-6% -$1.01M
CELG
35
DELISTED
Celgene Corp
CELG
$15.1M 1.74%
153,184
-6,200
-4% -$641K
BMY icon
36
Bristol-Myers Squibb
BMY
$130B
$3.49M 0.4%
47,500
-800
-2% -$56.5K
KHC icon
37
Kraft Heinz
KHC
$29.1B
$1.66M 0.19%
18,800
ADP icon
38
Automatic Data Processing
ADP
$107B
$1.42M 0.16%
15,500
LLY icon
39
Eli Lilly
LLY
$1.09T
$1.31M 0.15%
16,700
FE icon
40
FirstEnergy
FE
$27.2B
$1.14M 0.13%
32,500
BRK.B icon
41
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.09M 0.13%
7,500
IFF icon
42
International Flavors & Fragrances
IFF
$21.4B
$946K 0.11%
7,500
ZBH icon
43
Zimmer Biomet
ZBH
$18.7B
$927K 0.11%
7,931
A icon
44
Agilent Technologies
A
$41.9B
$896K 0.1%
20,200
CL icon
45
Colgate-Palmolive
CL
$73.6B
$893K 0.1%
12,200
COST icon
46
Costco
COST
$421B
$864K 0.1%
5,500
SO icon
47
Southern Company
SO
$106B
$863K 0.1%
16,100
GILD icon
48
Gilead Sciences
GILD
$168B
$751K 0.09%
9,000
RTX icon
49
RTX Corp
RTX
$300B
$677K 0.08%
10,487
AAPL icon
50
Apple
AAPL
$4.41T
$669K 0.08%
28,000

Similar funds

Stralem & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Stralem & Co held 54 positions worth $866M, down 5.3% from $915M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Stralem & Co withdrew a net $80M in Q2 2016, reducing 36 holdings. Its largest reduction was UnitedHealth, cutting an estimated $3.61M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Energy and Utilities.

Against the trend, Stralem & Co opened a new position in Archer Daniels Midland worth $202K.

  • Stralem & Co's largest Q2 2016 buy was Archer Daniels Midland: 4,700 shares worth $202K.
  • Stralem & Co's biggest Q2 2016 reduction was UnitedHealth, cutting an estimated $3.61M.
  • Stralem & Co's ten largest holdings make up 33% of its $866M portfolio in Q2 2016.
  • Stralem & Co opened 1 new position and closed 0 in Q2 2016.
  • Stralem & Co's portfolio value fell 5.3% quarter-over-quarter to $866M.

Based on Stralem & Co's 13F filing for Q2 2016, filed 19 Jul 2016.